top of page

Email:  bd@sidmexinovia.com | Phone:  +918866862020

  • Whatsapp
  • Instagram
  • Facebook
  • X
  • LinkedIn

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Pegihep 50mcg Injection

Pegihep 50mcg Injection

Manufacturer/Marketed By : Cadila Healthcare Ltd

$103.60 $80.81

Pegihep 50mcg Injection is an innovative biologic response modifier designed to combat viral infections, specifically targeting hepatitis B and C. This medication functions as a cytokine, a type of protein...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

Pegylated Interferon alpha 2B 50 mcg

Active Pharmaceutical Ingredient

Pegihep 50mcg Injection

SKU Cadila Healthcare Ltd
Prix d’origine

103,60$

Prix promotionnel

80,81$

Pegihep 50mcg Injection is an innovative biologic response modifier designed to combat viral infections, specifically targeting hepatitis B and C. This medication functions as a cytokine, a type of protein integral to enhancing the body's immune response. By elevating levels of interferon, Pegihep effectively stimulates the immune system to recognize and attack cancer cells and viral pathogens, acting as a defense mechanism against these foreign invaders. While Pegihep is generally well-tolerated, it is essential to be aware of potential side effects, including flu-like symptoms and changes in liver function. Patients should consult with their healthcare provider before use, particularly if they have pre-existing health conditions or are on other medications. As a vital part of hepatitis treatment regimens, Pegihep 50mcg Injection plays a crucial role in improving patient outcomes and overall health. Always follow your doctor’s guidance to ensure safe and effective use of this powerful therapy.

Active Pharmaceutical Ingredient

Pegylated Interferon alpha 2B 50 mcg

Uses

• Pegihep 50mcg injection is primarily used for the treatment of chronic Hepatitis B virus infections. This medication helps to reduce the viral load in the body, which can lead to improved liver function. By lowering the levels of the virus, Pegihep 50mcg injection may help prevent further liver damage. It is often administered as part of a comprehensive treatment plan for patients with this condition.
• Another significant use of Pegihep 50mcg injection is in the management of chronic Hepatitis C virus infections. This injection works to inhibit viral replication, thereby aiding in the control of the infection. Patients receiving Pegihep 50mcg injection may experience a decrease in the severity of their symptoms. This treatment is generally considered for individuals who have not responded adequately to other therapies.
• Pegihep 50mcg injection may also be utilized in patients with co-infections involving Hepatitis B and Hepatitis D viruses. The injection plays a crucial role in managing these complex cases by targeting the viral replication. By using Pegihep 50mcg injection, healthcare providers can help patients achieve better overall health outcomes. This targeted therapy is essential for those dealing with multiple viral infections.
• In addition to its antiviral effects, Pegihep 50mcg injection is sometimes used to improve the quality of life for patients suffering from chronic liver disease. It can help stabilize liver function and reduce complications associated with chronic hepatitis infections. Patients receiving Pegihep 50mcg injection may notice improvements in their overall well-being. This supportive role is vital in the long-term management of chronic liver conditions.

Benefits

Hepatitis B virus infection: The use of Pegihep 50mcg Injection plays a vital role in managing infections and optimising the functioning of the immune system. This reduces the likelihood of complications and leads to an improved quality of life. It is important to note that this medicine is always used in combination with other antiretroviral medicines and is not a cure for HCV infection. To ensure its effectiveness, it is important to take all doses at the times and in the amounts prescribed by your doctor.

Hepatitis C virus infection: The use of Pegihep 50mcg plays a vital role in managing infections and optimising the functioning of the immune system. This reduces the likelihood of complications and leads to an improved quality of life. It is important to note that this medicine is always used in combination with other antiretroviral medicines and is not a cure for HCV infection. To ensure its effectiveness, it is important to take all doses at the times and in the amounts prescribed by your doctor.

Side Effects

Like all medications, Pegihep Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Most Common Side Effects

• Pain in the Abdomen
• Low Appetite
• Blurred Vision
• Anxiety
• Fatigue
• Sore Throat
• Mouth Dryness
• Vomiting
• Dizziness
• Fatigue
• Nausea
• Mouth Ulcers

Common Side Effects

• Depression
• Nervousness
• Low count of white blood cells
• Sleeping Problems
• Problem in Concentration

How To Use

Pegihep 50mcg Injection must be given by a healthcare professional in a clinical or hospital setting. It is not advisable to attempt to administer it yourself.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Pegihep 50mcg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Caution should be exercised when using Pegihep 50mcg Injection in patients with kidney disease. It may be necessary to adjust doses of Pegihep Injection. It is advisable to consult your doctor for further advice and recommendations.
• Breastfeeding: Taking Pegihep 50mcg Injection while breastfeeding is not recommended as it passes into breast milk and may harm the baby. If you are currently breastfeeding and taking Pegihep 50mcg, it is important to discuss the potential risks and benefits associated with continuing to breastfeed with your doctor. You can make an informed decision about the health of both you and your baby based on your doctor's expertise.
• Liver: Caution should be exercised when using Pegihep 50mcg Injection in patients with liver disease. It may be necessary to adjust doses of Pegihep Injection. It is advisable to consult your doctor for further advice and recommendations.
• Pregnancy: It is advisable to avoid the use of Pegihep 50mcg Injection during pregnancy as evidence from animal studies suggests potential harm to the developing foetus. However, if you are currently pregnant or are considering becoming pregnant, it is important that you discuss the possible risks and benefits of using Pegihep 50 Injection during pregnancy with your doctor. Your doctor will advise you on how best to ensure that both you and your baby continue to thrive.
• Driving: Patients who experience fatigue, drowsiness, or confusion during treatment with Pegihep 50 Injection are cautioned not to drive. Avoid driving a car or operating machinery.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page